Donal O’Shea

A role for glucagon-like peptide-1 in the central regulation of feeding

Mandy D. Turton, Donal O’Shea, I. Gunn et al. · Nature · 1996 · 1.9K citations

Life Sciences, Endocrinology, Physiology +14

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Metabolic reprogramming of natural killer cells in obesity limits antitumor responses

Xavier Michelet, Lydia Dyck, Andrew E. Hogan et al. · Nature Immunology · 2018 · 610 citations

Life Sciences, Cancer Biology, Immunology +16

Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

Lydia Lynch, Michael Nowak, Bindu Varghese et al. · Immunity · 2012 · 496 citations · Full text

Life Sciences, Immunology, Physiology +16

Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat**This work was supported by the United Kingdom Medical Research Council.

Karim Meeran, Donal O’Shea, C. M. B. Edwards et al. · Endocrinology · 1999 · 305 citations

Medicine, Endocrinology, Pharmacology +17